|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Stock-based compensation expense, net of amounts capitalized | |||||
| Allowance for expected credit losses | |||||
| Inventory allowance | |||||
| Loss on disposal of property and equipment | |||||
| Change in fair value of warrant liability | |||||
| Paid-in-kind interest | |||||
| Loss on debt extinguishment | |||||
| Amortization of debt premium | |||||
| Amortization of debt issuance costs | |||||
| Write-off of financing fees | |||||
| Interest expense on financing obligation | |||||
| Goodwill impairment | |||||
| Intangibles impairment | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Operating lease liabilities | |||||
| Finance lease liabilities | |||||
| Accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Asset acquisition | |||||
| Business combination, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Proceeds from financing obligation | |||||
| Proceeds from Private Placement financing | |||||
| Transaction costs paid in connection with financing activities | |||||
| Proceeds from issuance of Series A preferred stock, net of issuance costs | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Proceeds from issuance of debt, net of issuance costs | |||||
| Proceeds from issuance of convertible note, net of debt issuance costs | |||||
| Payment of minimum employee taxes withheld upon net share settlement of restricted stock units | |||||
| Principal payment on finance lease liabilities | |||||
| Payment of debt modification or issuance costs | |||||
| Fractional shares paid in cash pursuant to Reverse Stock Split | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing activities: | |||||
| Conversion of Series A Preferred Stock to common stock | |||||
| Accrued interest capitalized to debt | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Non-cash transfer from property and equipment, net to other assets | |||||
| Stock-based compensation capitalized to property and equipment, net | |||||
| Interest capitalized to property and equipment, net | |||||
| Issuance of common stock for business combination | |||||
| Non-cash financing obligation activity | |||||
| Right-of-use asset obtained in exchange for operating lease liability | |||||
| Reduction of right of use asset and associated lease liability due to lease cancellation | |||||
| Warrants issued in connection with debt modification | |||||
| Non-cash equity settlement on employee receivable | |||||
| Reconciliation of cash, cash equivalents, and restricted cash from the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...